# TALOS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/talos

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.talos.kr
- Total disclosed funding: $2.9M
- Latest round: Series A (Dec 20, 2023)
- Investors on record: 6

## About

Based in Seoul, South Korea, and founded in 2021 by co-founders Kim Taek-kyun, Joo Jin-deok, Heo Jae-hyuk, Park Sang-joon, and Jeong Han-gil, TALOS specializes in developing advanced algorithms that predict the risk of serious diseases through the analysis of extensive medical big data. In December 2023, TALOS raised KRW 3.8 billion in Series A funding from investors Premier Partners, BA Partners, and Medinno Partners.


Talos' flagship product is ANRISK, a service that utilizes artificial intelligence algorithms to predict the risk of cerebral aneurysms based on health examination information. The technology enables healthcare providers to take early action, conducting additional examinations and brain imaging tests to address the risk of subarachnoid haemorrhage.


The company plans to use the funding to expand its platform services by recruiting key personnel and entering the overseas examination market.

## Funding rounds

- Series A, Dec 20, 2023, $2.9M — Premier Partners, BA Partners, Medinno Partners
- Seed, Apr 1, 2022 — Korea Tech Incubator for Startup, Medytox Venture Investment
- Seed, Aug 1, 2021 — Medytox Venture Investment, Hans Corporation

## Investors

- Medytox Venture Investment (https://capitalatlas.ai/funds/medytox-venture-investment) — Seed
- Hans Corporation — Seed
- Korea Tech Incubator for Startup — Seed
- Premier Partners (https://capitalatlas.ai/funds/premier-partners) — Series A
- BA Partners (https://capitalatlas.ai/funds/ba-partners) — Series A
- Medinno Partners — Series A